(Q37866752)

24 August 2017

1 reference

title

Modelling the epidemiology of infectious diseases for decision analysis: a primer (English)

1 reference

24 August 2017

1 reference

1 reference

1

Mark Jit

1 reference

24 August 2017

Marc Brisson

2

1 reference

24 August 2017

1 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

29

1 reference

24 August 2017

5

1 reference

24 August 2017

371-386

1 reference

https://scigraph.springernature.com/pub.10.2165/11539960-000000000-00000

24 August 2017

0 references

cites work

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination

1 reference

12 December 2020

Vaccination against rubella and measles: quantitative investigations of different policies

1 reference

12 December 2020

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

1 reference

12 December 2020

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

1 reference

12 December 2020

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra

1 reference

12 December 2020

Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.

1 reference

12 December 2020

WHO Guide for standardisation of economic evaluations of immunization programmes

1 reference

12 December 2020

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review

1 reference

12 December 2020

Herd immunity: basic concept and relevance to public health immunization practices

1 reference

12 December 2020

Characterizing structural uncertainty in decision analytic models: a review and application of methods

1 reference

12 December 2020

Economic evaluation of human papillomavirus vaccination in developed countries

1 reference

12 December 2020

The Australian model of immunization advice and vaccine funding.

1 reference

12 December 2020

Methodological issues and new developments in the economic evaluation of vaccines

1 reference

12 December 2020

Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis

1 reference

12 December 2020

Economic evaluation of human papillomavirus vaccination in the United Kingdom

1 reference

12 December 2020

Vaccination against colonizing bacteria with multiple serotypes

1 reference

12 December 2020

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

1 reference

12 December 2020

Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling

1 reference

12 December 2020

Targeted social distancing design for pandemic influenza

1 reference

12 December 2020

Methodological concerns with economic evaluations of meningococcal vaccines

1 reference

12 December 2020

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease

1 reference

12 December 2020

Handling uncertainty in cost-effectiveness models

1 reference

12 December 2020

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

1 reference

12 December 2020

Macroeconomic impact of HIV: the need for better modelling

1 reference

12 December 2020

1 reference

12 December 2020

Mathematical models of infectious disease transmission

1 reference

12 December 2020

The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands.

1 reference

12 December 2020

Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources

1 reference

12 December 2020

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

1 reference

12 December 2020

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Control of a highly pathogenic H5N1 avian influenza outbreak in the GB poultry flock.

1 reference

12 December 2020

Critical issues in the economic evaluation of interventions against communicable diseases

1 reference

12 December 2020

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

12 December 2020

Vaccines: past, present and future

1 reference

12 December 2020

Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness

1 reference

12 December 2020

Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy

1 reference

12 December 2020

Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza

1 reference

12 December 2020

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

1 reference

12 December 2020

Economic evaluations of varicella vaccination programmes: a review of the literature

1 reference

12 December 2020

Social contacts and mixing patterns relevant to the spread of infectious diseases

1 reference

12 December 2020

Funding of drugs: do vaccines warrant a different approach?

1 reference

12 December 2020

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

1 reference

12 December 2020

The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales

1 reference

12 December 2020

Delayed onset and diminished magnitude of rotavirus activity--United States, November 2007-May 2008.

1 reference

12 December 2020

Modelling mitigation strategies for pandemic (H1N1) 2009.

1 reference

12 December 2020

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

1 reference

12 December 2020

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

1 reference

12 December 2020

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

1 reference

12 December 2020

30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement

1 reference

12 December 2020

Cost-effectiveness of varicella vaccination programs: an update of the literature

1 reference

12 December 2020

Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec

1 reference

12 December 2020

Models of foot-and-mouth disease

1 reference

12 December 2020

Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes

1 reference

12 December 2020

Evidenced-based decision making about Hib vaccination

1 reference

12 December 2020

Using time-use data to parameterize models for the spread of close-contact infectious diseases

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes

1 reference

12 December 2020

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

1 reference

12 December 2020

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies

1 reference

12 December 2020

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

12 December 2020

Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature.

1 reference

12 December 2020

An introduction to Markov modelling for economic evaluation

1 reference

12 December 2020

Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries.

1 reference

12 December 2020

Early therapy for latent tuberculosis infection.

1 reference

12 December 2020

Modeling cervical cancer prevention in developed countries

1 reference

12 December 2020

A taxonomy of model structures for economic evaluation of health technologies.

1 reference

12 December 2020

10.2165/11539960-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

21504239

Dimensions Publication ID

24 August 2017

1018369246

0 references

Fatcat ID

release_s7cngacdrjbctfsxeoyyt2wdgm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s7cngacdrjbctfsxeoyyt2wdgm

24 November 2022

mapped directly with Wikidata item

0 references

1 reference

PubMed ID

21504239